Process for preparing clopidogrel
OwnerVinod Kumar Kansal, Kompally Praveen +1inventors
InventorsVinod Kumar Kansal, Kompally Praveen, Dhirenkumar N. Mistry
Life of this patent
Estimating the term…
Abstract
The present invention encompasses processes for the preparation of optically pure clopidogrel camphorsulfonic acid salt without the need to isolate or recover (±) clopidogrel.
Claims39
A process for preparing (−)-10-camphorsulphonic acid salt of methyl (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate comprising:
- (a) reacting 4,5,6,7-tetrahydrothieno (3,2-c) pyridine hydrochloride with o-chlorophenyl-α-bromo methyl acetate in the presence of an acid acceptor to produce (±)-methyl α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate;
- and (b) reacting in-situ (±)-methyl α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate with (−)-10-camphorsulphonic acid to provide (−)-10-camphorsulphonic acid salt of methyl (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate.
A process for preparing (S)-clopidogrel (−)-10-camphorsulphonic acid salt comprising:
- (a) combining (R) clopidogrel or a mixture of (R) and (S) clopidogrel with a base to obtain a racemic mixture of (R) and (S) clopidogrel further enriched with (S) clopidogrel;
- and (b) reacting the racemic mixture of (R) and (S) clopidogrel further enriched with (S) clopidogrel with levorotatory camphorsulphonic acid, to provide (S)-clopidogrel (−)-10-camphorsulphonic acid salt, wherein steps (a) and (b) are carried out without an intermediate step of reacting the racemic mixture of (R) and (S) clopidogrel with sulfuric acid.
A process for preparing clopidogrel camphosulfonate comprising combining 4,5,6,7-tetrahydrothieno-(3,2-c)pyridine hydrochloride, toluene, dimethyl formamide, o-chlorophenyl-α-bromo methyl acetate to obtain a reaction mixture containing (±) clopidogrel;
- and converting (±) clopidogrel to clopidogrel camphosulfonate without the recovery of (±) clopidogrel.
A process for preparing (S)-clopidogrel bisulfate comprising:
- (a) reacting 4,5,6,7-tetrahydrothieno (3,2-c) pyridine hydrochloride with o-chlorophenyl-α-bromo methyl acetate in the presence of an acid acceptor to produce (±)-methyl α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate;
- (b) reacting in-situ (±)-methyl α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate with (−)-10-camphorsulphonic acid to provide (−)-10-camphorsulphonic acid salt of methyl (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, wherein the camphorsulfonate precipitates out of reaction mixture leaving (R)-clopidogrel in the reaction mixture (mother liquor), optionally in a mixture with lesser amounts of (S)-clopidogrel;
- (c) combining the (R) clopidogrel or the mixture of (R) and (S) clopidogrel remaining in the reaction mixture (mother liquor) with a base to obtain a racemic mixture of (R) and (S) clopidogrel further enriched with (S) clopidogrel;
- (d) reacting the racemic mixture of (R) and (S) clopidogrel further enriched with (S) clopidogrel with levorotatory camphorsulphonic acid, to provide (S)-clopidogrel (−)-10-camphorsulphonic acid salt, wherein steps (c) and (d) are carried out without an intermediate step of reacting the racemic mixture of (R) and (S) clopidogrel with sulfuric acid;
- and
- (e) converting (S)-clopidogrel (−)-10-camphorsulphonic acid salt to (S)-clopidogrel bisulfate.
Dependencies are inferred from the claim text.